DE602005008970D1 - Verfahren und zusammensetzungen zur behandlung von augenerkrankungen mit retinyl-derivaten - Google Patents

Verfahren und zusammensetzungen zur behandlung von augenerkrankungen mit retinyl-derivaten

Info

Publication number
DE602005008970D1
DE602005008970D1 DE602005008970T DE602005008970T DE602005008970D1 DE 602005008970 D1 DE602005008970 D1 DE 602005008970D1 DE 602005008970 T DE602005008970 T DE 602005008970T DE 602005008970 T DE602005008970 T DE 602005008970T DE 602005008970 D1 DE602005008970 D1 DE 602005008970D1
Authority
DE
Germany
Prior art keywords
compositions
eye diseases
treating eye
retinyl derivatives
retinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005008970T
Other languages
English (en)
Inventor
Kenneth Widder
Jay Lichter
Nathan L Mata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
REVISION THERAPEUTIICS, INC. (N. D. GES. D. ST, US
Original Assignee
Sirion Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34981643&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602005008970(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sirion Therapeutics Inc filed Critical Sirion Therapeutics Inc
Publication of DE602005008970D1 publication Critical patent/DE602005008970D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology
    • G01N2800/164—Retinal disorders, e.g. retinopathy
DE602005008970T 2004-06-23 2005-06-06 Verfahren und zusammensetzungen zur behandlung von augenerkrankungen mit retinyl-derivaten Active DE602005008970D1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US58229304P 2004-06-23 2004-06-23
US62969504P 2004-11-19 2004-11-19
US66090405P 2005-03-11 2005-03-11
US67240505P 2005-04-18 2005-04-18
PCT/US2005/020080 WO2006007314A1 (en) 2004-06-23 2005-06-06 Methods and compositions for treating ophthalmic conditions with retinyl derivatives

Publications (1)

Publication Number Publication Date
DE602005008970D1 true DE602005008970D1 (de) 2008-09-25

Family

ID=34981643

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005008970T Active DE602005008970D1 (de) 2004-06-23 2005-06-06 Verfahren und zusammensetzungen zur behandlung von augenerkrankungen mit retinyl-derivaten

Country Status (27)

Country Link
US (3) US8314152B2 (de)
EP (3) EP2277516A1 (de)
JP (1) JP4855396B2 (de)
KR (1) KR100862930B1 (de)
AR (1) AR049929A1 (de)
AT (1) ATE404188T1 (de)
AU (1) AU2005262558B8 (de)
BR (1) BRPI0512569A (de)
CA (1) CA2569691C (de)
CY (1) CY1110435T1 (de)
DE (1) DE602005008970D1 (de)
DK (1) DK1768657T3 (de)
EA (1) EA011864B1 (de)
ES (1) ES2313368T3 (de)
GE (1) GEP20084520B (de)
HK (1) HK1107671A1 (de)
IL (1) IL179872A (de)
LV (1) LV13564B (de)
MX (1) MXPA06014978A (de)
NO (1) NO20070408L (de)
NZ (1) NZ551955A (de)
PL (1) PL1768657T3 (de)
PT (1) PT1768657E (de)
SG (1) SG140607A1 (de)
SI (1) SI1768657T1 (de)
TW (1) TWI396532B (de)
WO (1) WO2006007314A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1610772A4 (de) 2003-03-14 2008-06-18 Univ Washington Retinoid-ersatz und opsin-agonisten und anwendungsverfahren dafür
JP2007525496A (ja) * 2004-02-17 2007-09-06 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 黄班変性症を含む眼科疾患の管理
US7566808B2 (en) 2004-02-17 2009-07-28 President And Fellows Of Harvard College Management of ophthalmologic disorders, including macular degeneration
BRPI0507807A (pt) 2004-02-17 2007-07-31 Harvard College gerenciamento de distúrbios oftalmológicos, incluindo degeneração macular
KR101337321B1 (ko) 2004-06-18 2013-12-06 유니버시티 오브 워싱톤 시각 이상 치료를 위한 레티날 유도체 및 이를 이용하기위한 방법
AU2005262558B8 (en) 2004-06-23 2008-04-10 Revision Therapeutics, Inc. Methods and compositions for treating ophthalmic conditions with retinyl derivatives
US20060089411A1 (en) * 2004-08-07 2006-04-27 Gierhart Dennis L Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin
JP2008515778A (ja) * 2004-08-18 2008-05-15 シリオン セラピューティクス， インコーポレイテッド 眼の状態を１３−シス−レチニル誘導体で処置するための組み合わせ方法、組成物および治療
US8293253B2 (en) * 2004-10-28 2012-10-23 Idexx Laboratories, Inc. Compositions for controlled delivery of pharmaceutically active compounds
EP1807103A4 (de) * 2004-11-04 2009-02-11 Sirion Therapeutics Inc Modulatoren einer komplexen retinol-retinol-bindenden protein-transthyretin-formation
EA011154B1 (ru) * 2004-12-08 2009-02-27 Сирион Терапьютикс, Инк. Композиции для лечения ретинол-ассоциированных заболеваний
UA81382C2 (en) * 2005-07-11 2007-12-25 Composition for treating retinol-related diseases by modulation of retinol binding
US7754679B2 (en) * 2005-11-16 2010-07-13 Idexx Laboratories, Inc. Pharmaceutical compositions for the administration of aptamers
US8114440B2 (en) * 2005-11-16 2012-02-14 Idexx Laboratories Inc. Pharmaceutical compositions for the administration of aptamers
KR20090029814A (ko) * 2006-06-22 2009-03-23 시리온 테라퓨틱스, 인크. 메갈린 활성의 조절을 통한 안질환의 치료 방법 및 조성물
AU2007277033A1 (en) * 2006-07-27 2008-01-31 University Of Florida Research Foundation, Inc. Compositions and methods for treating or preventing ophthalmic disease
WO2008013983A2 (en) * 2006-07-27 2008-01-31 University Of Florida Research Foundation, Inc. Opsin stabilizing compounds and methods of use
WO2008013986A2 (en) * 2006-07-27 2008-01-31 University Of Florida Research Foundation, Inc. Compositions and methods for treating or preventing ophthalmic light toxicity
US8828960B2 (en) * 2007-07-17 2014-09-09 Idexx Laboratories, Inc. Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds
KR101810381B1 (ko) * 2008-02-11 2017-12-19 유니버시티 오브 워싱톤 스루 이츠 센터 포 커머셜리제이션 연령-관련 망막 기능장애의 치료 및 예방 방법
US8460635B2 (en) * 2008-03-12 2013-06-11 Albert Einstein College Of Medicine Of Yeshiva University Fenretinide derivatives and uses thereof as therapeutic, diagnostic and imaging agents
AU2009271129B2 (en) * 2008-07-14 2013-10-10 Otonomy, Inc. Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders
EP2427052B1 (de) * 2009-05-04 2015-08-26 Acucela, Inc. Zusammensetzungen zur verwendung in der behandlung von glaukom oder augenhochdruck
IN2012DN00352A (de) 2009-06-16 2015-08-21 Bikam Pharmaceuticals Inc
RU2546005C2 (ru) 2009-09-15 2015-04-10 Кью Эл Ти ИНК. Фармацевтические составы, содержащие 9-цис-ретиниловые сложные эфиры в липидном наполнителе
WO2011071995A2 (en) 2009-12-08 2011-06-16 Case Western Reserve University Compounds and methods of treating ocular disorders
JP6250389B2 (ja) 2010-04-19 2017-12-20 ノベリオン セラピューティクス インコーポレイテッド 内因性レチノイド欠損に関連する視覚障害を治療する又は改善する治療計画及び治療方法
JP6126118B2 (ja) 2011-11-30 2017-05-10 ビカム ファーマスーティカルス，インコーポレイテッド オプシン結合性リガンド、組成物、及び使用方法
TWI620578B (zh) * 2012-02-10 2018-04-11 台灣微脂體股份有限公司 用以減少眼用類固醇的倂發症之藥學組成物
KR102133608B1 (ko) 2012-03-01 2020-07-13 레티나제닉스, 엘엘씨 내인성 레티노이드 결핍증과 관련된 시각 장애에서 시각 기능의 개선을 위한 치료 요법 및 방법
US9011845B2 (en) 2012-06-26 2015-04-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods for treatment of inflammatory and infectious viral diseases
WO2014003850A2 (en) 2012-06-26 2014-01-03 Timothy Paul Foster Methods for treatment of ocular diseases
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
US10092393B2 (en) 2013-03-14 2018-10-09 Allotex, Inc. Corneal implant systems and methods
WO2015184453A1 (en) * 2014-05-30 2015-12-03 Case Western Reserve University Retinylamine derivitives for treatment of ocular disorders
MY183209A (en) 2014-10-24 2021-02-18 Takeda Pharmaceuticals Co Heterocyclic compound
CN107249678B (zh) * 2014-12-19 2021-02-19 凯敏工业公司 使用离子电渗法进行生物活性分子的眼内递送
US10449090B2 (en) 2015-07-31 2019-10-22 Allotex, Inc. Corneal implant systems and methods
PT3416622T (pt) * 2016-02-15 2023-08-28 Kemin Ind Inc Lipossomas com carga positiva como transportadores de moléculas lipofílicas
US11395853B2 (en) * 2016-06-23 2022-07-26 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Biomimetic drug delivery of an immunomodulatory agent for the treatment of ocular conditions
US11369695B2 (en) 2016-12-05 2022-06-28 The Jackson Laboratory Fat droplets in retina and optic nerve as a diagnostic marker for neurodegeneration and glaucoma in humans
TW201906635A (zh) * 2017-07-04 2019-02-16 日商第一三共股份有限公司 伴隨視細胞變性的視網膜變性的疾病用藥
BR112021022270A2 (pt) * 2019-05-06 2022-01-11 Univ California Materiais e métodos para tratar degeneração macular relacionada à idade

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190594A (en) 1975-11-03 1980-02-26 Johnson & Johnson Retinoic acid derivatives
US4323581A (en) 1978-07-31 1982-04-06 Johnson & Johnson Method of treating carcinogenesis
US4665098A (en) 1985-03-28 1987-05-12 Mcneilab, Inc. Pharmaceutical composition of N-(4-hydroxyphenyl) retinamide having increased bioavailability
US4874795A (en) 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4673044A (en) * 1985-08-02 1987-06-16 Eastman Christensen Co. Earth boring bit for soft to hard formations
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US4682663A (en) * 1986-02-18 1987-07-28 Reed Tool Company Mounting means for cutting elements in drag type rotary drill bit
US4743400A (en) * 1986-09-22 1988-05-10 Mcneilab, Inc. Process for preparing retinoyl chlorides
WO1991001745A1 (en) 1989-07-28 1991-02-21 Sloan-Kettering Institute For Cancer Research Growth factors containing vitamin a or other retinoids and uses thereof
US5814612A (en) * 1991-04-09 1998-09-29 Sloan-Kettering Institute For Cancer Research Retinol derivatives and uses thereof
US6506917B1 (en) * 1991-12-18 2003-01-14 The Salk Institute For Biological Studies Compounds and compositions useful for modulation of processes mediated by RXR
US6050354A (en) * 1992-01-31 2000-04-18 Baker Hughes Incorporated Rolling cutter bit with shear cutting gage
US5314909A (en) * 1993-03-17 1994-05-24 Merck & Co., Inc. Use of non-steroidal antiiflammatory agents in macular degeneration
US5399757A (en) * 1993-07-20 1995-03-21 Ortho Pharmaceutical Corporation Process for the preparation of N-(4-hydroxyphenyl)-retinamide
US5824685A (en) * 1995-02-01 1998-10-20 The Johns Hopkins University School Of Medicine Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
US5596011A (en) 1995-04-06 1997-01-21 Repine; Karen M. Method for the treatment of macular degeneration
US5702357A (en) * 1995-06-07 1997-12-30 Cobe Laboratories, Inc. Extracorporeal blood processing methods and apparatus
US5706906A (en) * 1996-02-15 1998-01-13 Baker Hughes Incorporated Superabrasive cutting element with enhanced durability and increased wear life, and apparatus so equipped
US5758733A (en) * 1996-04-17 1998-06-02 Baker Hughes Incorporated Earth-boring bit with super-hard cutting elements
US5846220A (en) * 1996-04-30 1998-12-08 Medtronic, Inc. Therapeutic method for treatment of Alzheimer's disease
US6034211A (en) * 1996-06-03 2000-03-07 Kelly; Jeffery W. β-sheet nucleating peptidomimetics
GB9621217D0 (en) * 1996-10-11 1996-11-27 Camco Drilling Group Ltd Improvements in or relating to preform cutting elements for rotary drill bits
WO1998027972A2 (en) 1996-12-23 1998-07-02 Texas A & M University Anti-amyloidogenic agents
US5955305A (en) * 1997-04-28 1999-09-21 Incyte Pharmaceuticals, Inc. Human retinoid binding protein
US5776915A (en) * 1997-08-12 1998-07-07 Clarion Pharmaceuticals Inc. Phosphocholines of retinoids
NZ502738A (en) 1997-08-15 2002-06-28 Univ Duke Triphenylethylene derivatives similar to tamoxifen or toremifene derivatives
US6482802B1 (en) * 1998-05-11 2002-11-19 Endowment For Research In Human Biology, Inc. Use of neomycin for treating angiogenesis-related diseases
US6669951B2 (en) 1999-08-24 2003-12-30 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
US7229961B2 (en) * 1999-08-24 2007-06-12 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into ocular tissues
CO5200852A1 (es) 1999-09-14 2002-09-27 Lilly Co Eli Moduladores rxr con mejorado perfil farmacologico ceptores x de los retinoides
CA2392453C (en) 1999-11-23 2012-03-20 Gerhart Graupner Modulation of signal transduction
US20020031539A1 (en) * 2000-08-30 2002-03-14 The Brigham And Women's Hospital, Inc. Oxidized forms of retinoic acid as ligands for peroxisome proliferator activated receptor gamma
CA2425196A1 (en) 2000-10-17 2002-04-25 Board Of Regents, The University Of Texas System A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes
US6408958B1 (en) * 2000-10-23 2002-06-25 Baker Hughes Incorporated Superabrasive cutting assemblies including cutters of varying orientations and drill bits so equipped
DK1349545T3 (da) 2000-12-05 2009-02-16 Los Angeles Childrens Hospital Farmaceutiske præparater af fenretinid med öget biotilgængelighed samt fremgangsmåder til anvendelse deraf
US20030032078A1 (en) * 2001-01-23 2003-02-13 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of macular and retinal degenerations
WO2002096857A1 (en) 2001-05-29 2002-12-05 Chebigen Co., Ltd. Novel retinoid derivatives and methods for producing said compounds and an anti-cancer pharmaceutical composition comprising said compounds
ES2255621T3 (es) * 2001-06-22 2006-07-01 MERCK & CO., INC. Inhibidores de tirosina quinasa.
WO2003003987A2 (en) 2001-07-06 2003-01-16 The Ohio State University Research Foundation Solid phase synthesis of arylretinamides
WO2003007944A1 (en) * 2001-07-20 2003-01-30 Qlt, Inc. Treatment of macular edema with photodynamic therapy
US20030229062A1 (en) 2001-12-07 2003-12-11 The Regents Of The University Of California Treatments for age-related macular degeneration (AMD)
US20040014131A1 (en) 2002-07-09 2004-01-22 Pfizer Inc. Assay methods
WO2004041160A2 (en) * 2002-10-30 2004-05-21 University Of Kentucky Research Foundation Methods and animal model for analyzing age-related macular degeneration
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
CA2509955A1 (en) 2002-11-29 2004-06-17 Gpc Biotech Ag Formulations useful against hepatitis c virus infections
SI21392A (sl) 2002-12-24 2004-06-30 Vinko Kunc Postopek za avtomatsko nastavitev ojačenja izpraševalnikovega sprejemnika v brezkontaktnem identifikacijskem sistemu
MXPA05008138A (es) 2003-01-31 2006-02-17 Los Angeles Childrens Hospital Composiciones orales de fenretinida que tienen biodisponibilidad incrementada y metodos de uso de las mismas.
FI20030426A (fi) 2003-03-24 2004-09-25 Tomi Jaervinen Syklodekstriinikompleksit
US7178609B2 (en) * 2003-08-19 2007-02-20 Baker Hughes Incorporated Window mill and drill bit
JP4869942B2 (ja) 2003-12-11 2012-02-08 ベス・イスラエル・ディーコネス・メディカル・センター，インコーポレイテッド インスリン感受性／抵抗性、糖尿病および肥満におけるｒｂｐ４
WO2005077176A1 (en) 2004-02-11 2005-08-25 The Trustees Of Columbia University In The City Of New York Anthocyanin compounds and methods of use thereof
BRPI0507807A (pt) * 2004-02-17 2007-07-31 Harvard College gerenciamento de distúrbios oftalmológicos, incluindo degeneração macular
US7566808B2 (en) 2004-02-17 2009-07-28 President And Fellows Of Harvard College Management of ophthalmologic disorders, including macular degeneration
CN1964706A (zh) 2004-03-17 2007-05-16 拉斯·M·拉森 通过抑制视觉周期预防视网膜病
KR101337321B1 (ko) 2004-06-18 2013-12-06 유니버시티 오브 워싱톤 시각 이상 치료를 위한 레티날 유도체 및 이를 이용하기위한 방법
AU2005262558B8 (en) 2004-06-23 2008-04-10 Revision Therapeutics, Inc. Methods and compositions for treating ophthalmic conditions with retinyl derivatives
US7286860B2 (en) 2004-07-23 2007-10-23 Dyna Llc Systems and methods for a comfortable wireless communication device
JP2008515778A (ja) 2004-08-18 2008-05-15 シリオン セラピューティクス， インコーポレイテッド 眼の状態を１３−シス−レチニル誘導体で処置するための組み合わせ方法、組成物および治療
EP1807103A4 (de) * 2004-11-04 2009-02-11 Sirion Therapeutics Inc Modulatoren einer komplexen retinol-retinol-bindenden protein-transthyretin-formation
EA011154B1 (ru) * 2004-12-08 2009-02-27 Сирион Терапьютикс, Инк. Композиции для лечения ретинол-ассоциированных заболеваний
UA81382C2 (en) * 2005-07-11 2007-12-25 Composition for treating retinol-related diseases by modulation of retinol binding

Also Published As

Publication number Publication date
DK1768657T3 (da) 2008-12-01
TWI396532B (zh) 2013-05-21
KR20070074541A (ko) 2007-07-12
HK1107671A1 (en) 2008-04-11
CA2569691C (en) 2010-08-17
EA200700109A1 (ru) 2007-10-26
TW200612891A (en) 2006-05-01
US8314152B2 (en) 2012-11-20
SG140607A1 (en) 2008-03-28
JP2008504257A (ja) 2008-02-14
US20100298443A1 (en) 2010-11-25
AU2005262558B2 (en) 2008-03-20
US20060167088A1 (en) 2006-07-27
LV13564B (en) 2008-02-20
NZ551955A (en) 2010-08-27
ES2313368T3 (es) 2009-03-01
IL179872A (en) 2013-01-31
NO20070408L (no) 2007-03-20
EP1768657B1 (de) 2008-08-13
CA2569691A1 (en) 2006-01-19
JP4855396B2 (ja) 2012-01-18
PT1768657E (pt) 2008-11-25
IL179872A0 (en) 2007-05-15
CY1110435T1 (el) 2015-04-29
KR100862930B1 (ko) 2008-10-13
PL1768657T3 (pl) 2009-01-30
ATE404188T1 (de) 2008-08-15
GEP20084520B (en) 2008-10-27
AU2005262558A1 (en) 2006-01-19
EA011864B1 (ru) 2009-06-30
US20110294891A1 (en) 2011-12-01
MXPA06014978A (es) 2007-04-25
SI1768657T1 (sl) 2009-02-28
BRPI0512569A (pt) 2008-03-25
EP1768657A1 (de) 2007-04-04
AR049929A1 (es) 2006-09-13
EP2277516A1 (de) 2011-01-26
AU2005262558B8 (en) 2008-04-10
US8410168B2 (en) 2013-04-02
EP2025336A1 (de) 2009-02-18
WO2006007314A1 (en) 2006-01-19

Similar Documents

Publication Publication Date Title
DE602005008970D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen mit retinyl-derivaten
ATE489955T1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
DE602005011656D1 (de) Verfahren zur behandlung von dickdarmkrebs mit botulinum neurotoxin
DE602004021790D1 (de) Verfahren zur behandlung von parkinson-krankheit
DE602006019753D1 (de) Verfahren und gerät zur behandlung von aneurysmen der a. thoracica
DE602006003500D1 (de) Verfahren und Vorrichtung zur Initialisierung von 10BASE-T Netzwerken
DE602005009537D1 (de) Änger mit niedriger zf und assoziiertes verfahren
DE602007006479D1 (de) Verfahren und vorrichtungen zur behandlung von mehreren bohrlochintervallen
DE602005015473D1 (de) Verfahren und mittel zur herstellung von hyaluronan
DE602006015182D1 (de) Zusammensetzung und verfahren zur kontrolle von insekten
DE602005004280D1 (de) Verfahren zum ziehen von sic-einkristallen und sic-einkristall
ATE474602T1 (de) Verfahren zur behandlung von hiv-infektion
DE602006005437D1 (de) Verfahren und Vorrichtung zum Herstellung von Bauteilen
DE602005015841D1 (de) Aroyl-o-piperidinderivate zur behandlung von problemen im zusammenhang mit diabetes
ATE461919T1 (de) Verfahren zur herstellung von montelukast und zwischenprodukte dafür
DE502007005222D1 (de) Vorrichtung und verfahren zur ansteuerung von personenschutzmittel
ATE488508T1 (de) Verfahren zur herstellung von irbesartan und zwischenprodukte davon
ATE406372T1 (de) Verfahren zur herstellung von 3-o-geschützten morphinonen und 3-o-geschützten morphinondienolcarboxylaten
ATE411803T1 (de) Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür
ATE427040T1 (de) Verfahren zur herstellung von nahrungsmitteln und so hergestelltes nahrungsmittel
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
ATE328880T1 (de) Tetrazolderivate und verfahren zur behandlung von stoffwechselbedingten erkrankungen damit
ATE463246T1 (de) Formulierung und verfahren zur behandlung von thrombocythämie
DE60327856D1 (de) Zusammensetzungen und verfahren zur hautbräunung
DE602006014555D1 (de) Verfahren zur herstellung von albumenfreiem fleischprodukt und dessen produkt

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: REVISION THERAPEUTIICS, INC. (N. D. GES. D. ST, US